Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06092606Phase 2Unknown
A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients
ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
PrincipalinvestigatorStart date: 2023-04-04

Research Network

Collaboration Network

42 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hui Zhou

Hunan Cancer Hospital

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hesheng He

The First Affilaited Hospital of Wannan Medical College

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Hongmei Jing

Peking University Third Hospital

Similar
4 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Xiaojia Wang

Zhejiang Cancer Hospital

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Zhenchang Sun

The First Affiliated Hospital of Zhengzhou University

Similar
1 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Jiwei Liu

The First Affiliated Hospital of Dalian Medical University

Similar
2 trials

Shared therapeutic areas:

Arrhythmias, CardiacCancerDoxorubicin Adverse Reaction+2 more

Worked with same sponsors:

Monyan Pharmaceutical (Shanghai) Co., Ltd.
Collaborated on 1 trial
Similarity Score54%

Andrea Natale, MD

Texas Cardiac Arrhythmia Research Foundation

Related
18 trials

Shared therapeutic areas:

Heart FailureArrhythmias, Cardiac
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Cancer
Similarity Score6%

Hamid Gourabi, PhD

head of Royan Institute

Related
52 trials

Shared therapeutic areas:

Heart Failure
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06092606Phase 2PrincipalInvestigator

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

ArrhythmiaCancerDoxorubicin Adverse Reaction+2 more
Unknown

All 1 trials loaded